Joseph Antin
Chief, Stem Cell Transplantation, Emeritus · Mass General Brigham
Credentials: · · · · ·
History
- Present
Stem Cell Transplantation Division · Mass General Brigham
- Present
- 1982–1984
- 1981–1982
1974–1978
Research
Journal of Clinical Oncology · 1997 · 1,031 citations
Interleukin-2 and regulatory T cells in graft-versus-host disease
New England Journal of Medicine · 2011 · 929 citations
Validation and refinement of the Disease Risk Index for allogeneic stem cell transplantation
Blood · 2014 · 858 citations
240 papers
219 papers · 4 as a fellow
183 papers · 2 as a fellow
147 papers
147 papers · 10 as a fellow
133 papers
89 papers · 3 as a fellow
67 papers
Grants
- 2001–2031
BMT CTN Core - Dana-Farber Cancer Institute and MGH Consortium
National Heart, Lung, and Blood Institute · UG1
Contact PI · $1.7M · Dana-Farber Cancer Inst
- 2001–2017
A Randomized Trial of Tac/MTX/Bortezomib vs Tac/MTXplacebo in Allogeneic HSCT
National Heart, Lung, and Blood Institute · U10
Contact PI · $1.1M · Dana-Farber Cancer Inst
- 2009–2015
Mechanisms, Prevention and Treatment of Chronic Graft-vs.-Host Disease
National Cancer Institute · P01
Contact PI · $9.4M · Dana-Farber Cancer Inst
- 2001–2011
Random Trial of CD8 T-Cell Depletion in PBSC Transplantation
National Heart, Lung, and Blood Institute · U01
Contact PI · $2.1M · Dana-Farber Cancer Inst
Clinical trials
- 2010–2013
Principal investigator · Completed
Dana-Farber Cancer Institute
- 2006–2012
Study of Parathyroid Hormone Following Sequential Cord Blood Transplantation From an Unrelated Donor
Principal investigator · Terminated · Phase 2
The Emmes Company, LLC
- 2003–2009
Phase I Study of Sequential Cord Blood Transplants
Principal investigator · Completed · Phase 1
Massachusetts General Hospital
- 2025–2029
Site PI · Recruiting · Phase 2
Medical College of Wisconsin